We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

155 hedge funds and large institutions have $1.42B invested in Agios Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 71 increasing their positions, 42 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 42

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

4% more capital invested

Capital invested by funds: $1.36B → $1.42B (+$61.2M)

1% less funds holding

Funds holding: 156 → 155 (-1)

2% less call options, than puts

Call options by funds: $8.24M | Put options by funds: $8.38M

Holders
155
Holders Change
-1
Holders Change %
-0.64%
% of All Funds
4.14%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
25
Increased
71
Reduced
42
Closed
22
Calls
$8.24M
Puts
$8.38M
Net Calls
-$136K
Net Calls Change
-$11.2M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.7M
2
CGT
Capital Guardian Trust
California
+$12.1M
3
BA
BlackRock Advisors
Delaware
+$11.9M
4
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
+$11.4M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$11.2M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$52.3M
2
Millennium Management
Millennium Management
New York
-$37.7M
3
Jennison Associates
Jennison Associates
New York
-$15.4M
4
State Street
State Street
Massachusetts
-$10.1M
5
GTC
Ghost Tree Capital
New York
-$5.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
CGL
51
Clarius Group LLC
Washington
$2M – – –
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.99M +$533K +10,800 +29%
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
$1.92M -$519K -10,514 -19%
OPPM
54
Opus Point Partners Management
New York
$1.81M -$381K -7,705 -15%
Goldman Sachs
55
Goldman Sachs
New York
$1.77M +$120K +2,423 +6%
TRSOTSOK
56
Teachers Retirement System of the State of Kentucky
Kentucky
$1.74M +$123K +2,500 +6%
PCM
57
Portolan Capital Management
Massachusetts
$1.69M -$115K -2,328 -5%
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$1.68M -$64.2K -1,300 -3%
UOTTAIMCU
59
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$1.68M +$1.98M +40,000 New
UBS Group
60
UBS Group
Switzerland
$1.65M +$1.69M +34,165 +646%
GH
61
GAM Holding
Switzerland
$1.65M +$183K +3,700 +10%
SAM
62
Sectoral Asset Management
Quebec, Canada
$1.51M +$1.78M +36,100 New
BG
63
Bellevue Group
Switzerland
$1.51M -$889K -18,000 -33%
Asset Management One
64
Asset Management One
Japan
$1.5M -$1.04M -21,144 -39%
AQR Capital Management
65
AQR Capital Management
Connecticut
$1.48M +$1.74M +35,308 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$1.47M +$452K +9,154 +35%
BlackRock
67
BlackRock
New York
$1.45M +$1.53M +30,958 +859%
GLRA
68
Gerald L. Ray & Associates
Texas
$1.44M +$711K +14,390 +72%
Jacobs Levy Equity Management
69
Jacobs Levy Equity Management
New Jersey
$1.39M +$1.64M +33,190 New
JP Morgan Chase
70
JP Morgan Chase
New York
$1.29M +$1.23M +25,005 +425%
AP
71
AlpInvest Partners
Netherlands
$1.26M +$1.48M +30,000 New
Capital Fund Management (CFM)
72
Capital Fund Management (CFM)
France
$1.25M +$1.47M +29,847 New
ProShare Advisors
73
ProShare Advisors
Maryland
$1.22M +$25.9K +525 +2%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.21M +$226K +4,574 +19%
CG
75
Cutler Group
California
$1.03M +$837K +16,958 +219%
1 2
3
4 5

AGIO Hedge Fund Activity: Q2 2016 in Review

155 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q2 2016, worth a combined $1.42B — up 4.5% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new AGIO positions and 22 closed out — a net gain of 3 holders — while 71 added to existing stakes and 42 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $29.7M. The largest seller was Capital World Investors, cutting an estimated $52.3M.

  • 155 institutional investors held Agios Pharmaceuticals (AGIO) as of Q2 2016, down from 156 in Q1 2016.
  • Funds reported $1.42B of Agios Pharmaceuticals stock for Q2 2016, up 4.5% quarter-over-quarter.
  • 25 funds opened new Agios Pharmaceuticals positions in Q2 2016 and 22 closed out, a net change of +3 holders.
  • The largest Agios Pharmaceuticals buyer in Q2 2016 was T. Rowe Price Associates, an estimated $29.7M added.
  • The largest Agios Pharmaceuticals seller in Q2 2016 was Capital World Investors, an estimated $52.3M sold.

Based on aggregated 13F filings for Q2 2016.